TUCSON, ARIZONA – February 13, 2024 – Avery Therapeutics, Inc. (“Avery”), a privately held, pre-clinical stage therapeutics company, proudly announces the successful qualification of their in-house cGMP pilot manufacturing facility for Phase I production in Tucson, AZ.Continue reading
Author Archive: AZBio
Flinn Foundation adds two Phoenix business leaders to its board of directors
Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.Continue reading
Bayer’s Expert Monday’s 2024
Bayer’s Expert Mondays – Knowledge Sharing to Empower Your Innovation Journey and Meet & Greet with Bayer Pharma Scouts.Continue reading
BIO5 Institute’s KEYS Research Internship Program Achieves Record Number of Applicants
[Tucson, Arizona] – The University of Arizona BIO5 Institute’s KEYS Research Internship program is thrilled to announce a groundbreaking surge in applications for its upcoming summer 2024 cohort. This year, the program received an unprecedented 430 applications, showcasing a tremendous interest from Arizona’s high school students aged 16 and older in the field of bioscience.Continue reading
Supporting Innovation – Now is the Time to Speak Up About R&D Expensing
Changes to the tax code revised the way R&D Expenses are treated at tax time. Congress created the policy that is now diverting dollars away from essential R&D. Congress can fix this. You can help them understand why they need to. Continue reading
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
Testing offers CBR families the opportunity to proactively seek additional information about their child’s healthContinue reading
Researchers develop new method to prevent prostate cancer chemoresistance
UArizona Cancer Center member Noel Warfel, PhD, co-led a research team that created and patented technology to combat anti-cancer drug resistance.Continue reading
SynCardia Systems LLC Announces Publication of Patent Application Covering Innovative Total Artificial Heart Design
Tucson, AZ, February 5th 2024 — SynCardia Systems, LLC., a Picard Medical Company, proudly announces that the U.S. Patent and Trademark Office (USPTO) has allowed claims of its groundbreaking patent application “Next Generation Total Artificial Heart” covering next generation total artificial heart designs.
The application describes novel technology aimed at eliminating external drive mechanisms by fully integrating the pumping mechanism within the implanted artificial heart ventricle. This new design represents a significant leap forward towards achieving a fully implantable system.Continue reading
Bill for Funding the Arizona Health Innovation Trust Fund Passes Senate Appropriations
SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024 and passed with unanimous support. On January 30, 2024, the bill received a do pass recommendation from Senate Appropriation with a vote of 7 ayes, 2 nays and 1 not voting
As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million. SB1019 is now is eligible for consideration by the Senate Rules Committee.Continue reading
AZBio Announces 2024 Officers and Directors
The Arizona Bioindustry Association, Inc. (AZBio) elected its 2024 officers at its January Board meeting. Continue reading